Please assess the completion status of the following clinical trial:

Trial Title: Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All primary hyperparathyroidism patients eligible for parathyroidectomy (PTx). Both bilateral and focused mode of PTx will be considered for this study, based on the surgeon's preference.~* Re-operative primary hyperparathyroidism patients who have undergone a failed prior PTx.~Exclusion Criteria:~* Patients with concurrent parathyroid and thyroid disease that require total thyroidectomy.~* Patients with secondary or tertiary hyperparathyroidism.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- NIRAF Detection Technology + (Type: EXPERIMENTAL): Parathyroid gland identification will be performed with PTeye using NIRAF detection technology as an adjunctive tool in patients who undergo parathyroidectomy (PTx).
- NIRAF Detection Technology - (Type: NO_INTERVENTION): Parathyroid gland identification will be performed with the naked eye of the surgeon without using PTeye - NIRAF detection technology in patients who undergo parathyroidectomy (PTx).

Based on this trial design, predict the completion outcome and termination type (if applicable).